Mifepristone and Corporate Responsibility

This chapter examines the legal and political challenges surrounding mifepristone, a medication pivotal to medication abortions in the U.S. It highlights Walgreens' decision to restrict its distribution in certain states amid a complex regulatory and political climate, emphasizing the impact on healthcare accessibility. The speakers express urgency regarding the implications of judicial rulings and the need for mobilization to protect reproductive rights ahead of the 2024 elections.